@pharmdidi.bsky.social
Interventions to prevent bloodstream infections associated with central venous access devices: Priorities for an adaptive platform trial - American Journal of Infection Control www.ajicjournal.org/article/S019...
Interventions to prevent bloodstream infections associated with central venous access devices: Priorities for an adaptive platform trial
Health care-associated bloodstream infections are serious complications of central
venous access devices. Numerous preventative interventions exist, but without high-level
evidence. The IVCare adaptiv...
www.ajicjournal.org
November 10, 2025 at 12:52 PM
New strategies for a vexing problem: injectables to the rescue for people with Multidrug-Resistant HIV
✅ Just Accepted
🔗 https://bit.ly/4ovrYCU
✅ Just Accepted
🔗 https://bit.ly/4ovrYCU
November 10, 2025 at 12:51 PM
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Mortality and Causes of Death in Patients with Mycobacterium avium Complex Isolates through 28 years
This nationwide study of 2,027 Danish patients with MAC isolates (1991-2018) revealed declining mortality. Age, male sex, DMAC, and comorbidities were asso
bit.ly
November 10, 2025 at 12:50 PM
Lessons Learned from A Geriatric Referral Model in People with HIV
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3LgHN1o
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3LgHN1o
November 2, 2025 at 9:13 PM
🆕🌟Excellent review article
P2Y12 inhibitors(eg clopidogrel,ticagrelor)in Staphylococcus aureus bacteraemia: current evidence and clinical implications
Coming soon: CLOPI-SNAP+ Clopido-SNAP #idsky #EMIMCC
www.thelancet.com/journals/lan...
P2Y12 inhibitors(eg clopidogrel,ticagrelor)in Staphylococcus aureus bacteraemia: current evidence and clinical implications
Coming soon: CLOPI-SNAP+ Clopido-SNAP #idsky #EMIMCC
www.thelancet.com/journals/lan...
P2Y12 inhibitors in Staphylococcus aureus bacteraemia: current evidence and clinical implications
Staphylococcus aureus bacteraemia presents a substantial clinical burden, with high
rates of morbidity and mortality. Despite its severity, therapeutic advancements have
been small in the past decade,...
www.thelancet.com
November 2, 2025 at 9:12 PM
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
#IDSky
#IDSky
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19
We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant immunocompromise in the phase 3 CANOPY trial.
bit.ly
November 2, 2025 at 9:11 PM
Clever use of two Greek mythological metaphors to talk about cefiderocol mechanism of action and resistance.
#IDSky #ClinMicro #AMR
academic.oup.com/jac/advance-...
#IDSky #ClinMicro #AMR
academic.oup.com/jac/advance-...
The Achilles’ heel of the Trojan Horse? A systematic evaluation of cefiderocol susceptibility testing
Abstract. Cefiderocol, an innovative siderophore cephalosporin, presents a novel therapeutic option against a spectrum of multidrug-resistant (MDR) Gram-ne
academic.oup.com
October 25, 2025 at 12:51 AM
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024
#IDSky
#IDSky
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024
The 2023–2024 influenza season included sustained elevated activity from December 2023 to February 2024 and continued activity through May 2024. Influenza A(H1N1), A(H3N2), and B viruses circulated during the season.
bit.ly
October 25, 2025 at 12:50 AM
Trichomonas vaginalis Among Cisgender Women Taking Doxycycline Postexposure Prophylaxis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3W4CLr3
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3W4CLr3
October 16, 2025 at 2:53 PM
COVID-19 and Bacterial Pneumonia: Protective Effect or Diagnostic Bias?
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4mPrcPw
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4mPrcPw
October 8, 2025 at 7:48 PM
Secondary Pneumococcal Disease in Veterans with Viral Respiratory Infections: a Follow Up
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WhVjUG
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3WhVjUG
October 8, 2025 at 7:47 PM
Host-directed therapies for infectious disease are here & coming!
Simple equation proposed to consider best interventions:
⭐ Microorganism + immune response = clinical presentation/status ⭐
Will require futuristic-sounding real-time diagnostics = exciting!
#IDSky #MedSky #ImmunoSky #TBSky
Simple equation proposed to consider best interventions:
⭐ Microorganism + immune response = clinical presentation/status ⭐
Will require futuristic-sounding real-time diagnostics = exciting!
#IDSky #MedSky #ImmunoSky #TBSky
The Changing Paradigm in Infectious Diseases - Host-Directed Medicine: Implications for the Next Generation of ID Physicians
academic.oup.com
October 2, 2025 at 6:24 PM
New research article
Rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit: a single-centre prospective observational study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #OpenAccess #OA
Rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit: a single-centre prospective observational study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #OpenAccess #OA
October 2, 2025 at 6:22 PM
Is empirical antifungal therapy the next path forward in patients with influenza-associated ARDS?
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gEI3mC
✅ Just Accepted
#IDSky
🔗 https://bit.ly/4gEI3mC
September 23, 2025 at 8:34 PM
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study
In this study of 172 ICU patients with influenza-related ARDS, empirical antifungal treatment was associated with reduced pulmonary aspergillosis incidence
bit.ly
September 23, 2025 at 8:32 PM
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
#IDSky
#IDSky
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Clinical guidelines recommend initiation of antiviral therapy as soon as possible for patients hospitalized with confirmed or suspected influenza.
bit.ly
September 18, 2025 at 1:40 PM
Multidrug-resistant yeast cases rising rapidly in Europe, survey shows
Data from a new survey show Candida auris, which can cause deadly invasive infections, is spreading rapidly in European hospitals.
www.cidrap.umn.edu/c...
Data from a new survey show Candida auris, which can cause deadly invasive infections, is spreading rapidly in European hospitals.
www.cidrap.umn.edu/c...
September 12, 2025 at 3:11 PM
Switching to oral therapy has become an option for treating infective endocarditis in select patients. In CID, authors assess its effectiveness in real-life settings, including patients not eligible in current guidelines. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf452/8237289
Should we extend the use of oral antibiotics in infective endocarditis? The ENDO-ORAL study
This real-life study showed that switching from intravenous to oral antibiotic therapy in infective endocarditis was effective and safe, including in patie
academic.oup.com
September 3, 2025 at 12:00 PM
On Science Speaks blog: Several authors of IDSA’s new guidelines on the management and treatment of complicated urinary tract infections answer questions about new recommendations and updates. www.idsociety.org/science-spea...
Complicated urinary tract infections: New guidelines Q&A
Several authors of IDSA’s new guidelines for treating and managing complicated urinary tract infections answer questions about the recommendations and highlight key updates.
www.idsociety.org
September 3, 2025 at 12:12 AM
Excited to share the updated CDC yellow book chapter on Immunocompromised Host and travel, here is the official updated website from the CDC. Let me know if you have questions or comments. www.cdc.gov/yellow-book/...
Immunocompromised Travelers
Tailor vaccine and medicine recommendations based on international travelers’ immune systems.
www.cdc.gov
April 27, 2025 at 12:55 PM
Impact of macrolide resistance on azithromycin for prevention of rehospitalization or death among children discharged from hospitals in Western Kenya
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Impact of macrolide resistance on azithromycin for prevention of rehospitalization or death among children discharged from hospitals in Western Kenya
We hypothesized that macrolide resistance in gut microbes could modify azithromycin’s effect. Methods From June 2016 to November 2019, Kenyan children aged 1-59 months were enrolled at hospital discharge and randomized to azithromycin or placebo.
doi.org
April 27, 2025 at 12:53 PM